3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
4
Metastatic Castration-resistant Prostate Cancer
2
Breast Neoplasms
2
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Fanconi Anemia, Complementation Group D1
1
Endometrial Neoplasms
1
Interventions
selpercatinib
2
larotrectinib
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
sapanisertib
1
repotrectinib
1
relatlimab
1
pralsetinib
1
pertuzumab
1
pembrolizumab
1
palbociclib
1
osimertinib
1
omipalisib
1
ipatasertib
1
erdafitinib
1
defactinib
1
dabrafenib
1
copanlisib
1
capivasertib
1
cabozantinib
1
binimetinib
1
adavosertib
1
X-Rays
1
Trastuzumab
1
Sunitinib
1
Specimen Handling
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Thyroid Neoplasms
×
olaparib
×
Clear all
No trials found.